Quick Answer
BioAge Labs, Inc. reported Net Income Loss of -$80.61 million for the year ending 2025.
- BioAge Labs, Inc. showed a decrease of -13.4% in Net Income Loss from 2024 to 2025.
- This data is from BioAge Labs, Inc.'s annual report (Form 10-K), filed with the SEC on March 24, 2026.
- XBRL data for this metric is available from 2023 to 2025 (3 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2023: -$11.08 million | Q2 2023: -$17.19 million | Q3 2023: -$14.63 million | Q1 2024: -$12.99 million | Q2 2024: -$13.58 million | Q3 2024: -$23.41 million | Q1 2025: -$12.93 million | Q2 2025: -$21.56 million | Q3 2025: -$20.17 million.
- Over the full 3 years of available data (2023 to 2025), BioAge Labs, Inc.'s Net Income Loss has declined by 26.2%.
- Historical annual values: Fiscal year 2025: -$80.61 million | Fiscal year 2024: -$71.11 million | Fiscal year 2023: -$63.85 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: